Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-imino-13-deoxydoxorubicin HCl |
---|---|
Date Designated: | 12/31/2015 |
Orphan Designation: | Treatment of soft tissue sarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Monopar Therapeutics, Inc. 5 Revere Drive Suite 200 Northbrook, Illinois 60062 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-